The variable expression of these markers in the tumor cells of the melanoma itself showed (i) no specific correlation with the spatial distribution of the hypoxia-associated antigen GLUT-1 and (ii) no impact on patient prognosis. The gene discussed is SLC2A1; the disease is neoplasm.